NuVasive 3Q Forecast Shows Disappointing Revenue Decrease

NuVasive forecasted a fall in third quarter revenue, from $154.4 million in the second quarter to approximately $147 million, according to a Bloomberg Businessweek report.

Advertisement

The fall in revenue was driven by competitor discounts and an increase in coverage denials and delays by healthcare payors. The device company will release its third quarter financial results later this month.

More Articles on Orthopedic Devices:

13 Spine Devices Receive FDA 510(k) Clearance in September

How A Facility Implements Generic Orthopedic Implants 

Pinnacle Spine Group Wins FDA Approval for Direct Lateral System

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.